KRISTI SIKES: Open Payments
NPI 1881989788 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 26 payments from 12 companies in 2025. Trend: 2023 $846 · 2024 $545 · 2025 $642
Food & beverage: $530Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $144 |
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| Bausch Health US, LLC | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Indivior Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $18 |
Products named: REXULTI, INGREZZA, CAPLYTA, APLENZIN, ABILIFY ASIMTUFII, COBENFY, Auvelity, VRAYLAR.
Industry payments across TX — which companies pay providers there.
